IL-31: A new key player in dermatology and beyond.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29366565.
- Also identified by DOI 10.1016/j.jaci.2017.10.045.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
IL-31 is a novel cytokine expressed in many human tissues and involved mainly in T<sub>H</sub>2-weighted inflammation. IL-31 signals through a receptor complex consisting of IL-31 receptor α and oncostatin M receptor β. The available data show that IL-31 is strongly linked with chronic pruritic skin disorders, such as atopic eczema, and represents a novel target for directed drug therapy. Regulation of immune responses and cellular differentiation and proliferation are recently elucidated effects of IL-31, suggesting a more complex and diverse area of effect for this novel cytokine. This review summarizes the current knowledge on IL-31 and its receptors and the involvement of IL-31 in diseases both in human subjects and mouse models.
Medical subject headings
- Cell Differentiation
- Cell Proliferation
- Dermatitis, Atopic
- Interleukins
- Receptors, Interleukin